Report Detail
Global Certolizumab pegol Market 2019 by Company, Regions, Type and Application, Forecast to 2024
- RnM3646055 |
- 06 August, 2019 |
- Global |
- 102 Pages |
- GIR (Global Info Research) |
- Pharma & Healthcare
Certolizumab pegol (CDP870, tradename Cimzia) is a biologic medication for the treatment of Crohn's disease, rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis.
Scope of the Report:
The global Certolizumab pegol market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Certolizumab pegol.
Europe also play important roles in global market, with market size of xx million USD in 2019 and will be xx million USD in 2024, with a CAGR of xx%.
This report studies the Certolizumab pegol market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Certolizumab pegol market by product type and applications/end industries.
Market Segment by Companies, this report covers
UCB
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Single-dose vial
Single-dose prefilled syringe
Market Segment by Applications, can be divided into
Crohn’s disease
Active rheumatoid arthritis
Active psoriatic arthritis
Table of Contents
1 Certolizumab pegol Market Overview
- 1.1 Product Overview and Scope of Certolizumab pegol
- 1.2 Classification of Certolizumab pegol by Types
- 1.2.1 Global Certolizumab pegol Revenue Comparison by Types (2019-2024)
- 1.2.2 Global Certolizumab pegol Revenue Market Share by Types in 2018
- 1.2.3 Single-dose vial
- 1.2.4 Single-dose prefilled syringe
- 1.3 Global Certolizumab pegol Market by Application
- 1.3.1 Global Certolizumab pegol Market Size and Market Share Comparison by Applications (2014-2024)
- 1.3.2 Crohn’s disease
- 1.3.3 Active rheumatoid arthritis
- 1.3.4 Active psoriatic arthritis
- 1.4 Global Certolizumab pegol Market by Regions
- 1.4.1 Global Certolizumab pegol Market Size (Million USD) Comparison by Regions (2014-2024)
- 1.4.1 North America (USA, Canada and Mexico) Certolizumab pegol Status and Prospect (2014-2024)
- 1.4.2 Europe (Germany, France, UK, Russia and Italy) Certolizumab pegol Status and Prospect (2014-2024)
- 1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Certolizumab pegol Status and Prospect (2014-2024)
- 1.4.4 South America (Brazil, Argentina, Colombia) Certolizumab pegol Status and Prospect (2014-2024)
- 1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Certolizumab pegol Status and Prospect (2014-2024)
- 1.5 Global Market Size of Certolizumab pegol (2014-2024)
2 Manufacturers Profiles
- 2.1 UCB
- 2.1.1 Business Overview
- 2.1.2 Certolizumab pegol Type and Applications
- 2.1.2.1 Product A
- 2.1.2.2 Product B
- 2.1.3 UCB Certolizumab pegol Revenue, Gross Margin and Market Share (2017-2018)
3 Global Certolizumab pegol Market Competition, by Players
- 3.1 Global Certolizumab pegol Revenue and Share by Players (2014-2019)
- 3.2 Market Concentration Rate
- 3.2.1 Top 5 Certolizumab pegol Players Market Share
- 3.2.2 Top 10 Certolizumab pegol Players Market Share
- 3.3 Market Competition Trend
4 Global Certolizumab pegol Market Size by Regions
- 4.1 Global Certolizumab pegol Revenue and Market Share by Regions
- 4.2 North America Certolizumab pegol Revenue and Growth Rate (2014-2019)
- 4.3 Europe Certolizumab pegol Revenue and Growth Rate (2014-2019)
- 4.4 Asia-Pacific Certolizumab pegol Revenue and Growth Rate (2014-2019)
- 4.5 South America Certolizumab pegol Revenue and Growth Rate (2014-2019)
- 4.6 Middle East and Africa Certolizumab pegol Revenue and Growth Rate (2014-2019)
5 North America Certolizumab pegol Revenue by Countries
- 5.1 North America Certolizumab pegol Revenue by Countries (2014-2019)
- 5.2 USA Certolizumab pegol Revenue and Growth Rate (2014-2019)
- 5.3 Canada Certolizumab pegol Revenue and Growth Rate (2014-2019)
- 5.4 Mexico Certolizumab pegol Revenue and Growth Rate (2014-2019)
6 Europe Certolizumab pegol Revenue by Countries
- 6.1 Europe Certolizumab pegol Revenue by Countries (2014-2019)
- 6.2 Germany Certolizumab pegol Revenue and Growth Rate (2014-2019)
- 6.3 UK Certolizumab pegol Revenue and Growth Rate (2014-2019)
- 6.4 France Certolizumab pegol Revenue and Growth Rate (2014-2019)
- 6.5 Russia Certolizumab pegol Revenue and Growth Rate (2014-2019)
- 6.6 Italy Certolizumab pegol Revenue and Growth Rate (2014-2019)
7 Asia-Pacific Certolizumab pegol Revenue by Countries
- 7.1 Asia-Pacific Certolizumab pegol Revenue by Countries (2014-2019)
- 7.2 China Certolizumab pegol Revenue and Growth Rate (2014-2019)
- 7.3 Japan Certolizumab pegol Revenue and Growth Rate (2014-2019)
- 7.4 Korea Certolizumab pegol Revenue and Growth Rate (2014-2019)
- 7.5 India Certolizumab pegol Revenue and Growth Rate (2014-2019)
- 7.6 Southeast Asia Certolizumab pegol Revenue and Growth Rate (2014-2019)
8 South America Certolizumab pegol Revenue by Countries
- 8.1 South America Certolizumab pegol Revenue by Countries (2014-2019)
- 8.2 Brazil Certolizumab pegol Revenue and Growth Rate (2014-2019)
- 8.3 Argentina Certolizumab pegol Revenue and Growth Rate (2014-2019)
- 8.4 Colombia Certolizumab pegol Revenue and Growth Rate (2014-2019)
9 Middle East and Africa Revenue Certolizumab pegol by Countries
- 9.1 Middle East and Africa Certolizumab pegol Revenue by Countries (2014-2019)
- 9.2 Saudi Arabia Certolizumab pegol Revenue and Growth Rate (2014-2019)
- 9.3 UAE Certolizumab pegol Revenue and Growth Rate (2014-2019)
- 9.4 Egypt Certolizumab pegol Revenue and Growth Rate (2014-2019)
- 9.5 Nigeria Certolizumab pegol Revenue and Growth Rate (2014-2019)
- 9.6 South Africa Certolizumab pegol Revenue and Growth Rate (2014-2019)
10 Global Certolizumab pegol Market Segment by Type
- 10.1 Global Certolizumab pegol Revenue and Market Share by Type (2014-2019)
- 10.2 Global Certolizumab pegol Market Forecast by Type (2019-2024)
- 10.3 Single-dose vial Revenue Growth Rate (2014-2024)
- 10.4 Single-dose prefilled syringe Revenue Growth Rate (2014-2024)
11 Global Certolizumab pegol Market Segment by Application
- 11.1 Global Certolizumab pegol Revenue Market Share by Application (2014-2019)
- 11.2 Certolizumab pegol Market Forecast by Application (2019-2024)
- 11.3 Crohn’s disease Revenue Growth (2014-2019)
- 11.4 Active rheumatoid arthritis Revenue Growth (2014-2019)
- 11.5 Active psoriatic arthritis Revenue Growth (2014-2019)
12 Global Certolizumab pegol Market Size Forecast (2019-2024)
- 12.1 Global Certolizumab pegol Market Size Forecast (2019-2024)
- 12.2 Global Certolizumab pegol Market Forecast by Regions (2019-2024)
- 12.3 North America Certolizumab pegol Revenue Market Forecast (2019-2024)
- 12.4 Europe Certolizumab pegol Revenue Market Forecast (2019-2024)
- 12.5 Asia-Pacific Certolizumab pegol Revenue Market Forecast (2019-2024)
- 12.6 South America Certolizumab pegol Revenue Market Forecast (2019-2024)
- 12.7 Middle East and Africa Certolizumab pegol Revenue Market Forecast (2019-2024)
13 Research Findings and Conclusion
14 Appendix
- 14.1 Methodology
Summary:
Get latest Market Research Reports on Certolizumab pegol. Industry analysis & Market Report on Certolizumab pegol is a syndicated market report, published as Global Certolizumab pegol Market 2019 by Company, Regions, Type and Application, Forecast to 2024. It is complete Research Study and Industry Analysis of Certolizumab pegol market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
